KOD - Small-Cap Biotech Stocks That Could Help Boost Your Portfolio's Health

Despite starting the year off strong, biotech stocks have had a rough summer. The recent weakness in the biotech sector is causing biotech exchange-traded funds (ETFs) like the VanEck Vectors Biotech ETF (BBH), the iShares NASDAQ Biotechnology ETF (IBB), and the SPDR S&P Biotech ETF (XBI) to drop steeply.

Some believe the reason for the six consecutive weeks of outflows from biotech ETFs is due to the growing debate over the House’s high-profile drug pricing bill, which has the potential to do further damage if approved. Meanwhile, analysts are suggesting the sector is lagging due to ...